The Natural History of Graft-Versus-Host Disease in the Eyes

计划入组 61 人 · 首次发布于 2011 年 6 月 9 日

Treatment of Ocular Graft-versus-Host Disease (GVHD) With Topical Loteprednol Etabonate 0.5%

计划入组 75 人 · 首次发布于 2012 年 9 月 28 日

Ocular Graft Versus Host Disease After Hematopoietic Stem Cell Transplantation in Adults

计划入组 120 人 · 首次发布于 2009 年 6 月 3 日

allogeneic umbilical cord mesenchymal stem cell therapy (ocular graft-versus-host disease)

Graft-versus-host disease therapeutics (Mallinckrodt)

Graft-versus-host disease therapy(Applied StemCell, Inc.)

Ocular Therapeutix

United States

Ocular Therapeutix, Inc.

United States

Vascular Graft Solutions Ltd.

Israel

FDA Aligns with Signal12 on Phase 3 Trial Design for Novel Ocular GVHD Therapy Pro-ocular

Adipose-Derived Stem Cell Injections Show Promise in Treating Inflammatory Eye Diseases

FDA Grants IND Clearance for Immunoglobulin Eye Drops to Treat Dry Eye Disease